ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 247

$608K Total Retail Price of All Prescriptions

Rank: 23 out of 247

462 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

4% of this provider’s 7,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 475 391 1 3
SIMVASTATIN 425 335 2 1
FUROSEMIDE 389 295 3 5
LISINOPRIL 386 319 4 2
METOPROLOL TARTRATE 262 209 5 7
OMEPRAZOLE 250 180 6 4
ATENOLOL 196 162 7 10
TRAMADOL HCL 177 155 8 25
HYDROCODONE-ACETAMINOPHEN 174 132 S3 9 11
WARFARIN SODIUM 172 103 10 13
METFORMIN HCL 166 119 11 12
SERTRALINE HCL 162 119 12 16
PANTOPRAZOLE SODIUM 153 110 13 19
HYDROCHLOROTHIAZIDE 151 138 14 9
DONEPEZIL HCL 108 108 15 35
ATORVASTATIN CALCIUM 107 101 16 8
AMLODIPINE BESYLATE 102 102 17 6
GLYBURIDE 100 74 R 18 41
POTASSIUM CHLORIDE 90 59 19 36
LANTUS 88 50 20 39
TAMSULOSIN HCL 82 57 21 31
LIDODERM 79 67 22 74
ALLOPURINOL 76 68 23 33
RANITIDINE HCL 74 49 24 34
CLOZAPINE 73 18 25 194
CYCLOBENZAPRINE HCL 73 45 R 25 54
ZOLPIDEM TARTRATE 69 55 27 24
FENTANYL 69 45 S2 27 72
TRAZODONE HCL 69 44 27 28
OLANZAPINE 68 57 30 106
OXYCODONE HCL 66 0 S2 31 27
NAMENDA 62 62 32 47
MELOXICAM 62 34 32 70
LOVASTATIN 60 47 34 22
AZITHROMYCIN 59 47 35 48
LOSARTAN POTASSIUM 58 56 36 15
ENALAPRIL MALEATE 57 53 37 61
DIOVAN 56 56 38 38
ISOSORBIDE MONONITRATE ER 53 49 39 40
PROAIR HFA 53 21 39 29
DIGOXIN 52 32 41 83
BENZTROPINE MESYLATE 52 42 R 41 228
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.